Velmanase alfa-tycv
Velmanase alfa-tycv is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Lamzede. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- Velmanase alfa-tycv
- Brand Names
- Lamzede
- Application Number
- BLA761278
- Sponsor
- Chiesi USA, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- VELMANASE ALFA-TYCV
Indications and Usage
1 INDICA TIONS AND USAGE LAMZEDE is indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. LAMZEDE is recombinant human lysosomal alpha-mannosidase indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. ( 1 )